CClinicalTrials.gg
CompletedNCT04029506Updated Jul 23, 2019

Medical Staff: Higher Risk for Gastrointestinal Polypoid Lesions

An observational study in the Incidence of Gastrointestinal Diseases Diagnosed by Endoscopy in Physicians and General Population, sponsored by Shandong University. Completed at 1 site in China. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2019-07-23.

Sponsored by Shandong University · Observational

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
878
Ages
18 Years to 85 Years
Sex
All
01

Study summary

This is a single center, retrospective, propensity score-matched analyzed study. Patients who underwent gastroscopy and colonoscopy for physical examination in Qilu Hospital of Shandong University, China, from January 2017 to September 2018, were retrospectively reviewed to compare the incidence of gastrointestinal diseases diagnosed by endoscopy between physicians and general population.

Read the detailed description

This is a single center, retrospective, propensity score-matched analyzed study. Patients who underwent gastroscopy and colonoscopy for physical examination in Qilu Hospital of Shandong University, China, from January 2017 to September 2018, were retrospectively reviewed.To compare the incidence of gastrointestinal diseases diagnosed by endoscopy between physicians and general population.

02

Conditions studied

  • the Incidence of Gastrointestinal Diseases Diagnosed by Endoscopy in Physicians and General Population
03

In context

Gastrointestinal Diseases

628 studies on the registry are indexed under Gastrointestinal Diseases; 128 are open to participants now.

This study's enrollment of 878 is above the median of 325 across 190 observational studies indexed under Gastrointestinal Diseases.

Browse Gastrointestinal Diseases studies →

Lead sponsor

Shandong University is the lead sponsor of 284 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who underwent gastroscopy and colonoscopy for physical examination in Qilu Hospital of Shandong University, China, from January 2017 to September 2018, were retrospectively reviewed. Subjects who had a history of gastrointestinal surgery or subjects who did not finish the endoscopic examination were excluded. All selected subjects were age- and sex- matched to form two groups: Group 1, medical staff from Qilu Hospital, and Group 2, general population.

Inclusion criteria

  • Patients who underwent gastroscopy and colonoscopy for physical examination in Qilu Hospital from January 2017 to September 2018

Exclusion criteria

Exclusion Criteria:

  • Subjects who had a history of gastrointestinal surgery or subjects who did not finish the endoscopic examination were excluded
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
878 participants (actual)
Patient registry
No

Groups and cohorts

  • medical staff group

    medical staff in Qilu Hospital who recieveing endoscopy for physical examination

  • general population group

    general population who recieveing endoscopy for physical examination in Qilu Hospital

06

What researchers measure

Primary outcomes

  1. the incidence of gastrointestinal diseases diagnosed by endoscopy between physicians and general population.

    Time frame: 12 months

07

Study locations

1 site
  • Qilu Hospital of Shandong University
    Jinan, Shandong, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04029506
Lead sponsor
Shandong University
Responsible party
Xiuli Zuo (Ph.D, Shandong University) — Principal investigator
First posted
Jul 23, 2019
Start date
Jan 1, 2019
Primary completion
Jan 30, 2019
Completion
Feb 1, 2019
Last update
Jul 23, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion